Biodexa Pharmaceuticals (BDRX) EBT Margin Growth (1y) (2016 - 2020)
Powered by 
Analysis
Biodexa Pharmaceuticals (BDRX) EBT Margin Growth (1y) (2016 - 2020) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 209.88 Bn | 195.89 Bn | 7.24 Bn | 1,045.00 |
| 2 | Gilead Sciences | 179.94 Bn | 176.76 Bn | 6.22 Bn | -16,571.00 |
| 3 | Vertex Pharmaceuticals | 131.92 Bn | 124.07 Bn | 2.84 Bn | -153.00 |
| 4 | Regeneron Pharmaceuticals | 81.96 Bn | 73.96 Bn | 3.93 Bn | -571.00 |
| 5 | Argenx Se | 61.21 Bn | 56.02 Bn | 1.37 Bn | 553.00 |
| 6 | Moderna | 53.53 Bn | 48.39 Bn | 52.00 Mn | 4,709.00 |
| 7 | Alnylam Pharmaceuticals | 33.65 Bn | 30.34 Bn | 992.69 Mn | 1,911.00 |
| 8 | Biogen | 31.83 Bn | 30.55 Bn | 1.96 Bn | -2,328.00 |
| 9 | Roivant Sciences | 29.64 Bn | 29.64 Bn | 1.16 Mn | -801,907.00 |
| 10 | Biodexa Pharmaceuticals | 49.27 Mn | 37.92 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2020 | -1.16 Mn |
| Dec 31, 2019 | -209,717.00 |
| Dec 31, 2018 | -21,962.00 |
| Dec 31, 2017 | 10,077.00 |
| Dec 31, 2016 | 22,297.00 |